Skip to main content

Find Clinical Trials

Home
Conditions
Hypopigmentation

Clinical trial condition

Hypopigmentation

Explore clinical trials studying Hypopigmentation. Study availability and eligibility vary by location and protocol.

221 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Hypopigmentation trial results

Completed

A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo

NCT05750823

Conditions: Hypopigmentation, Nonsegmental Vitiligo With Genital Involvement, Pigmentation Disorders, +3 more
Locations: Center For Dermatology Clinical Research, Inc Fremont, California, United States

Vitiligo & Pigmentation Institute of Southern California Los Angeles, California, United States

Hamzavi Dermatology Fort Gratiot, Michigan, United States

Apex Clinical Research Center Mayfield, Ohio, United States

View all 13 locations

View Trial Details

Completed

Translational Assessment of Vitiligo According to Body Locations

NCT06068218

Conditions: Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations: CHU de Nice - Hôpital de l'Archet Nice, Alpes-maritimes, France

View Trial Details

Completed

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

NCT05544448

Conditions: Acquired Bone Marrow Aplasia, Alopecia, Arthritis, +43 more
Locations: Hôpital Henri Mondor, 1 rue Gustave Eiffel, Créteil, Île-de-France Region, France

View Trial Details

Completed

Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

NCT07368673

Conditions: Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations: Dow University of health sciences Karachi, Sindh, Pakistan

View Trial Details

Completed

Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population

NCT04658381

Conditions: Albinism, Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Hôpital Fondation A. de Rothschuld Paris, France

View Trial Details

Completed

Tofacitinib for Immune Skin Conditions in Down Syndrome

NCT04246372

Conditions: Abnormalities, Multiple, Alopecia, Alopecia Areata, +40 more
Locations: Linda Crnic Institute for Down Syndrome Aurora, Colorado, United States

View Trial Details

Completed

Mental Health Associations With Vitiligo

NCT04953338

Conditions: Adjustment Disorders, Anxiety Disorders, Behavior, +27 more
Locations: Momentum Data Ltd London, United Kingdom

View Trial Details

Completed

A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

NCT07174024

Conditions: Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations: Cairo University Giza, Cairo Governorate, Egypt

View Trial Details

Completed

ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation

NCT04843059

Conditions: Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations: CHU de Nice Nice, alpes maritimes, France

CHU Bordeaux Bordeaux, France

View Trial Details

Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

NCT04057573

Conditions: Hypopigmentation, Non-Segmental Vitiligo, Pigmentation Disorders, +3 more
Locations: Desert Sky Dermatology Gilbert, Arizona, United States

Center For Dermatology Cosmetic and Laser Surgery Fremont, California, United States

Uci Beckman Laser Institute and Medical Clinic Irvine, California, United States

UCI Health Beckman Laser Institute and Medical Center Irvine, California, United States

View all 76 locations

View Trial Details